Chemoradiotherapy, with adjuvant surgery for local control, confers a durable survival advantage in adenocarcinoma and squamous cell carcinoma of the oesophagus.

Thumbnail
Name:
Publisher version
Authors
Bass, G A
Furlong, H
O'Sullivan, K E
Hennessy, T P J
Walsh, T N
Affiliation
Royal College of Surgeons in Ireland, Department of Surgery, Connolly Hospital, Dublin 15, Ireland. Electronic address: garybassmd@gmail.com.
Issue Date
2014-04
Keywords
CANCER
Local subject classification
CHEMOTHERAPY
RADIOTHERAPY
MeSH
Adenocarcinoma
Adult
Aged
Carcinoma, Squamous Cell
Chemoradiotherapy
Cohort Studies
Combined Modality Therapy
Esophageal Neoplasms
Esophagus
Female
Follow-Up Studies
Humans
Lymphatic Metastasis
Male
Middle Aged
Randomized Controlled Trials as Topic
Survival Analysis
Treatment Outcome

Metadata
Show full item record
Citation
Bass GA et al. Chemoradiotherapy, with adjuvant surgery for local control, confers a durable survival advantage in adenocarcinoma and squamous cell carcinoma of the oesophagus. Eur. J. Cancer 2014, 50 (6):1065-75
Journal
European journal of cancer (Oxford, England : 1990)
URI
http://hdl.handle.net/10147/323550
DOI
10.1016/j.ejca.2013.12.022
PubMed ID
24480403
Abstract
Oesophageal cancer usually presents with systemic disease, necessitating systemic therapy. Neo-adjuvant chemoradiotherapy improves short-term survival, but its long-term impact is disputed because of limited accrual, treatment-protocol heterogeneity and a short follow-up of randomised trials.
Item Type
Other
Language
en
ISSN
1879-0852
Collections